Neuronostics Revenue and Competitors
Employee Data
- Neuronostics has 15 Employees.
- Neuronostics grew their employee count by 25% last year.
Neuronostics's People
Name | Title | Email/Phone |
---|
Neuronostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 5 | -29% | N/A | N/A |
#2 | $15M | 215 | 16% | N/A | N/A |
#3 | N/A | 5700 | -13% | N/A | N/A |
#4 | N/A | 166 | 32% | N/A | N/A |
#5 | N/A | 134 | 29% | N/A | N/A |
#6 | N/A | 54 | 26% | N/A | N/A |
#7 | N/A | 233 | 23% | N/A | N/A |
#8 | N/A | 244 | 24% | N/A | N/A |
#9 | N/A | 110 | 25% | N/A | N/A |
#10 | N/A | 177 | 34% | N/A | N/A |
What Is Neuronostics?
At Neuronostics we are reimagining the way neurological conditions are diagnosed, treated, and monitored. We use the power of mathematical modelling to develop novel biomarkers that create faster paths to diagnosis and effective treatment. \n\nOur first clinical indication, BioEP is an entirely new digital biomarker of epilepsy BioEP uses background EEG data and mathematical modelling to predict the likelihood of seizures. Our BioEP risk score supports clinical diagnostic and prognostic decisions of epilepsy.\n\nOur vision is that digital biomarkers are used routinely in neurology centres around the world to create a more proactive and anticipatory model of care. This will revolutionise neurological healthcare and radically improve the lives of people at risk of or living with neurological conditions.
keywords:N/AN/A
Total Funding
15
Number of Employees
N/A
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 15 | 25% | N/A |
#2 | $2.2M | 15 | -29% | N/A |
#3 | $1.2M | 15 | 25% | N/A |
#4 | $1.9M | 15 | -35% | N/A |
#5 | N/A | 15 | -44% | $4M |